Moonwalk Biosciences, Inc.

Biotechnology
Sponsors visas
Lately:7 news stories in 90 daysFollow changes →

Facts

as of Nov 17, 2026

By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed.

Legal name
Moonwalk Biosciences, Inc.
Headquarters
South San Francisco, United States
Founded
2022
Employees
201-500estimated range
Register numbers
NAME moonwalk biosciences inc
Official records
SEC CIK 2004362
Website
moonwalk.bio

These are the key facts about Moonwalk Biosciences, Inc. on Alion as of Nov 17, 2026. Moonwalk Biosciences, Inc. is headquartered in South San Francisco, United States. It was founded in 2022. It has raised $127M in 2 funding rounds. The latest round is Series B of $70M, announced in 2026.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Moonwalk Biosciences, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Named in the work visa registers of United States.

United StatesUS 1 #5,756 of 8,997 sponsors
1H-1B filings in 12 months
$123kMedian offered salary
0Open roles in United States
Who they sponsor
Other biological scientists1
The salary offered for each occupationVisa pass · 90 credits

In the register as Moonwalk Biosciences, Inc., South San Francisco, CA

Other sponsors in the same field
Alert me
US Department of Labor · latest filing May 20, 2026

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
South San Francisco United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$127MTotal raised
Series BLatest round
2Rounds and grants
Money by yearUSD, rounds and grants
2026$70M1 record
2024$57M1 record
Largest rounds and grants
$70M
$57M
Sources: funding announcements, grant and company registers

Milestones

Sep 8
Jan 5, 2024
2022
Founded
Each milestone is dated by its source: registers, filings, the press

Newsroom

Sep 282026
News · pharmexec.com
Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platfor…
Sep 212026
News · RFWrightLSL
On this weeks episode of the Business of Biotech, Alex Aravanis, M.D., Ph.D., CEO of Moonwalk Biosciences, talks about the opportunity in obesity beyond GLP-1s.
Sep 92026
News · YahooFinance
The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today
Sep 82026
News · Pulse 2.0
Moonwalk Biosciences has raised an oversubscribed $70 million Series B financing to advance its pipeline of adipose-targeted RNA interference medicines for obesity and cardiometa…
Sep 82026
News · YahooFinance
SOUTH SAN FRANCISCO & SAN DIEGO, September 08, 2026--Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Card…
Sources: the outlets named on each headline, each story once